Not applicableStudy completedNCT05153018What this trial is testingPopulation Immunity AgaiNst mosquitO-borne Diseases in VanuatuWho this might be right forArbovirus DiseaseZikaDengue+3 more Institut Pasteur 1,122
Not applicableLooking for participantsNCT01386424What this trial is testingScreening for LID Clinical Studies Unit Healthy Volunteer ProtocolsWho this might be right forZikaInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Early research (Phase 1)Looking for participantsNCT06805487What this trial is testingEvaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP ChallengeWho this might be right forZika Virus National Institute of Allergy and Infectious Diseases (NIAID) 26
Early research (Phase 1)Study completedNCT03014089What this trial is testingSafety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult SubjectsWho this might be right forZika Virus ModernaTX, Inc. 90
Not applicableStudy completedNCT03553277What this trial is testingSpatial Repellents for Arbovirus ControlWho this might be right forArbovirus Infections University of Notre Dame 18,240
Not applicableStudy completedNCT04343521What this trial is testingQuantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne DiseasesWho this might be right forAedes-borne DiseasesDengueChikungunya+1 more Emory University 4,461
Early research (Phase 1)Study completedNCT03611946What this trial is testingSafety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve AdultsWho this might be right forZika Virus National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableStudy completedNCT03776903What this trial is testingEvaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISAWho this might be right forZika Virus Infection InBios International, Inc. 600
Early research (Phase 1)Study completedNCT04033068What this trial is testingSafety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001)Who this might be right forZika Virus Infection Themis Bioscience GmbH 48
Not applicableStudy completedNCT04182685What this trial is testingEvaluation of Medical Conditions Associated With Zika Virus Infection in Managua, NicaraguaWho this might be right forZika Virus RTI International 410
Not applicableUnknownNCT05589012What this trial is testingEvaluation of Viral Replication by Tonate Virus (TONV) and Zika Virus (ZIKV), Within an ex Vivo Trophoblast and Placental ModelWho this might be right forZika Virus Infection Assistance Publique - Hôpitaux de Paris 8
Not applicableActive Not RecruitingNCT06651372What this trial is testingThe Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return TravelersWho this might be right forArbovirus Infections University Hospital, Strasbourg, France 200
Early research (Phase 1)Study completedNCT04064905What this trial is testingSafety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative AdultsWho this might be right forZika Virus ModernaTX, Inc. 120
Early research (Phase 1)Active Not RecruitingNCT06334393What this trial is testingPhase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy AdultsWho this might be right forZikaZika Virus Infection Valneva Austria GmbH 150
Not applicableStudy completedNCT05452447What this trial is testingSpatial Repellents for Aedes-borne Virus Control in Sri LankaWho this might be right forArbovirus Infections University of Notre Dame 6,949
Not applicableUnknownNCT04672577What this trial is testingInfection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and MalariaWho this might be right forTravel-Related IllnessMalariaDengue+6 more Patricia Schlagenhauf 10,000
Early research (Phase 1)Study completedNCT04478656What this trial is testingSafety and Immunogenicity of BBV121Who this might be right forZika Virus Infection Bharat Biotech International Limited 48
Early research (Phase 1)Study completedNCT03008122What this trial is testingPhase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic AreaWho this might be right forZika Virus Infection National Institute of Allergy and Infectious Diseases (NIAID) 91
Early research (Phase 1)Study completedNCT04440774What this trial is testingResearch Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.Who this might be right forChikungunyaZika University of Oxford 120
Not applicableStudy completedNCT02979938What this trial is testingUnderstanding Excretion and Infectivity of Zika Virus in Semen During and After InfectionWho this might be right forZika Virus Trinidad and Tobago IVF and Fertility Centre 25